BioTech Medics Statistics
Total Valuation
BioTech Medics has a market cap or net worth of 2.83 million.
| Market Cap | 2.83M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
BioTech Medics has 202.36 million shares outstanding.
| Current Share Class | 202.36M |
| Shares Outstanding | 202.36M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.03 |
| PB Ratio | 0.93 |
| P/TBV Ratio | 0.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01, with a Debt / Equity ratio of 0.01.
| Current Ratio | 0.01 |
| Quick Ratio | 0.00 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.87 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -19.06% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.07% in the last 52 weeks. The beta is 21.61, so BioTech Medics's price volatility has been higher than the market average.
| Beta (5Y) | 21.61 |
| 52-Week Price Change | -36.07% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 55.12 |
| Average Volume (20 Days) | 7,193 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, BioTech Medics had revenue of 469,799 and -603,722 in losses. Loss per share was -0.00.
| Revenue | 469,799 |
| Gross Profit | 408,137 |
| Operating Income | -583,311 |
| Pretax Income | -603,722 |
| Net Income | -603,722 |
| EBITDA | 33,355 |
| EBIT | -583,311 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 2,614 in cash and 29,110 in debt, giving a net cash position of -26,496 or -0.00 per share.
| Cash & Cash Equivalents | 2,614 |
| Total Debt | 29,110 |
| Net Cash | -26,496 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 3.06M |
| Book Value Per Share | 0.02 |
| Working Capital | -2.00M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 86.87%, with operating and profit margins of -124.16% and -128.51%.
| Gross Margin | 86.87% |
| Operating Margin | -124.16% |
| Pretax Margin | -128.51% |
| Profit Margin | -128.51% |
| EBITDA Margin | 7.10% |
| EBIT Margin | -124.16% |
| FCF Margin | n/a |
Dividends & Yields
BioTech Medics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -21.31% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on November 16, 2007. It was a reverse split with a ratio of 0.05.
| Last Split Date | Nov 16, 2007 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
BioTech Medics has an Altman Z-Score of -1.23. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.23 |
| Piotroski F-Score | n/a |